➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
Moodys
Johnson and Johnson
Mallinckrodt
Boehringer Ingelheim
Dow

Last Updated: September 22, 2020

DrugPatentWatch Database Preview

Patent: 10,456,164

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 10,456,164
Title:Anti-microbial medical injection assemblies for onabotulinumtoxina delivery and methods of use thereof
Abstract: A medical injection assembly is provided and includes an introducer with a handle, a sheath, a scope lumen configured to receive an endoscope at a first proximal end of the handle and hold the endoscope in a desired position, a cap attached to the distal end of the scope lumen configured to isolate the scope lumen from the external environment, and a cannula lumen configured to receive a cannula at a second proximal end of the handle and hold the cannula in a desired position. The medical injection assembly includes a cannula configured such that the distance between the distal tip of the cannula and the axis defined by the sheath of the introducer increases as the cannula is moved in a distal direction and a syringe.
Inventor(s): Snoke; Phillip Jack (Winston-Salem, NC), Allred, III; Philip Morrison (Kernersville, NC), Smith; John Joseph (Winston-Salem, NC)
Assignee: URO-1, INC. (Winston-Salem, NC)
Application Number:15/722,168
Patent Claims:see list of patent claims

Details for Patent 10,456,164

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Allergan BOTOX onabotulinumtoxina VIAL; SINGLE-USE 103000 001 1991-12-09   Start Trial URO-1, INC. (Winston-Salem, NC) 2039-11-21 RX search
Allergan BOTOX onabotulinumtoxina VIAL; SINGLE-USE 103000 002 1991-12-09   Start Trial URO-1, INC. (Winston-Salem, NC) 2039-11-21 RX search
Allergan BOTOX onabotulinumtoxina VIAL; SINGLE-USE 103000 003 1991-12-09   Start Trial URO-1, INC. (Winston-Salem, NC) 2039-11-21 RX search
Allergan BOTOX COSMETIC onabotulinumtoxina VIAL; SINGLE-USE 103000 004 1991-12-09   Start Trial URO-1, INC. (Winston-Salem, NC) 2039-11-21 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Baxter
Moodys
Johnson and Johnson
McKinsey
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.